Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Wagner Charles F Jr
Relationship:   EVP & Chief Financial ...
City:   Billerica
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   228,237    

Indirect Shares

  0      
Direct Value   $33,490,857    

Indirect Value

  $0      
Total Shares   228,237      
Total Value   $33,490,857      


Progress Software Corp
 $5,250,399 Bruker Corp
 $5,846,612 Vertex Pharmaceuticals Inc
 $22,393,846 Progress Software Corp
 $5,250,399 Bruker Corp
 $5,846,612 Vertex Pharmaceuticals Inc
 $22,393,846
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progress Software Corp PRGS EVP Finance & Admin an... 2011-10-14 81,175 0    Premium*  
            Bruker Corp BRKR EVP & Chief Financial ... 2015-03-17 99,925 2012-08-02 0    Premium*  
            Vertex Pharmaceuticals Inc VRTX EVP & Chief Financial ... 2024-06-03 47,137 2019-04-10 0    Premium*  
* Premium Members only  

Records found :    47         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
PRGS Progress Software Corp EVP Finance & Admin and CFOOff   •       –      –    2010-11-15 3 IO $0.00 $0 D/D 0 32,000 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-05-02 4 AS $254.87 $88,778 D/D (343) 42,730 0 -
VRTX Vertex Pharmaceuticals In... EVP and CFO   •       –      –    2020-02-24 4 D $239.23 $129,663 D/D (542) 17,274 0 -
VRTX Vertex Pharmaceuticals In... EVP and CFO   •       –      –    2020-04-30 4 D $251.78 $137,724 D/D (547) 16,727 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-24 4 D $217.57 $119,011 D/D (547) 35,226 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-04-30 4 D $217.21 $118,814 D/D (547) 34,679 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-29 4 D $276.17 $151,065 D/D (547) 43,073 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2020-07-10 4 AS $291.19 $205,206 D/D (700) 16,126 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-24 4 AS $305.38 $539,912 D/D (1,768) 49,611 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-17 4 AS $294.52 $592,786 D/D (2,000) 51,379 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-10 4 AS $286.64 $604,709 D/D (2,088) 56,045 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-24 4 D $227.86 $498,786 D/D (2,189) 49,373 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-10 4 D $214.16 $506,488 D/D (2,365) 35,773 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-10 4 D $237.74 $578,659 D/D (2,434) 55,001 0 -
PRGS Progress Software Corp EVP Finance & Admin and CFO   •       –      –    2011-04-01 4 D $29.53 $75,112 D/D (2,544) 45,456 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-01 4 AS $261.42 $683,602 D/D (2,582) 43,620 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-09 4 D $422.74 $1,102,083 D/D (2,607) 63,454 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-03-13 4 AS $288.31 $783,346 D/D (2,666) 53,379 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-10 4 D $294.33 $796,751 D/D (2,707) 70,183 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-02-20 4 D $420.58 $1,182,671 D/D (2,812) 56,892 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-02 4 AS $250.07 $736,206 D/D (2,944) 57,435 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-11-20 4 AS $349.88 $1,049,640 D/D (3,000) 46,693 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2024-01-02 4 AS $405.00 $1,215,000 D/D (3,000) 43,693 0 %
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-30 4 D $20.26 $62,036 D/D (3,062) 118,925 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-03-17 4 AS $250.13 $793,218 D/D (3,171) 46,202 0 -

  47  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed